RxDoctor Payments Data

Laura Stevenson, PA

Medical · Valencia, CANPI 1437116639

Payments from drug & device makers

$10,243in general payments, 2019–2025

Across 323 payments — averaging $31.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Journey Medical Corporation$2K
  • Sanofi$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Johnson & Johnson$775
  • AbbVie$709
  • Lilly USA, LLC$633
  • plus $3K from 19 others

What the payments were for

  • Speaking & faculty fees$2,00020%
  • Food & beverage$7,77376%
  • Education$4705%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,243 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.

See all medical providers in California

Medicare billing

Part B allowed, 2024
$235,587
Medicare patients
931
Services billed
3,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa16$317,369
Cosentyx Sensoready (2 Pens)Secukinumab12$89,881
Fluorouracil64$4,589
Clobetasol Propionate59$2,913
Tacrolimus13$1,689
Metronidazole26$1,171
Doxycycline Hyclate24$1,012
Fluocinonide43$931
Ketoconazole75$903
Econazole Nitrate12$495
Clindamycin Phosphate19$484
ValacyclovirValacyclovir Hcl14$421
Ciclopirox11$387
Triamcinolone Acetonide34$162
Cephalexin53$111

Paid to pharmacies, not to this prescriber.

Other medical in Valencia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →